Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.52 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29587981 | 0.83 | SLC1A2 (0.64) | APOBEC3GSLC1A2NPC1RAB9AL3MBTL1 | |
| SCHEMBL28790425 | 0.80 | EHMT2 (0.52) | EHMT2EHMT1APOBEC3GL3MBTL1POLB | |
| SCHEMBL16710901 | 0.80 | APOBEC3G (0.52) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL16710804 | 0.78 | EHMT2 (0.48) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL1126670 | 0.77 | EHMT2 (0.52) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL12729631 | 0.76 | EHMT2 (0.47) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL775626 | 0.75 | TAAR1 (0.50) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL537743 | 0.75 | EHMT2 (0.59) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL17833858 | 0.75 | ALDH1A1 (0.57) | EHMT2EHMT1APOBEC3GNPC1RAB9A | |
| SCHEMBL327697 | 0.74 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361302-A1 | ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF | TUFTS COLLEGE (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4490168-A1 | CTLA-4 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS AND USES THEREOF | Molecular Templates, Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| US-12180262-B2 | CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors | MOLECULAR TEMPLATES, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-12065469-B2 | De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals | MOLECULAR TEMPLATES, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20240092860-A1 | CD38-BINDING PROTEINS COMPRISING DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTORS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2024-03-21 | — | — | US | disclosed |
| US-20240082404-A1 | SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2024-03-14 | — | — | US | disclosed |
| US-11918649-B2 | PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds | MOLECULAR TEMPLATES, INC. (US) | 2024-03-05 | — | — | US | disclosed |
| US-20230331785-A1 | HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS | ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE | 2023-10-19 | — | — | US | disclosed |
| WO-2023172983-A1 | CTLA-4 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS AND USES THEREOF | MOLECULAR TEMPLATES, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| US-11713347-B2 | CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| WO-2020190733-A1 | pHLIP®-MEDIATED TARGETING OF CORTICOSTEROIDS TO DISEASED TISSUE | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2020-09-24 | — | — | WO | disclosed |
| WO-2020154531-A1 | CD38-BINDING PROTEINS COMPRISING DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2020-07-30 | — | — | WO | disclosed |
| WO-2017046658-A1 | DERIVATIVES OF AMANITA TOXINS AND THEIR CONJUGATION TO A CELL BINDING MOLECULE | HANGZHOU DAC BIOTECH CO, LTD (CN) | 2017-03-23 | — | — | WO | disclosed |
| EP-2283042-A2 | ISOLATED MONOCLONAL ANTIBODY OR FRAGMENT THEREOF BINDING PROSTATE SPECIFIC MEMBRANE ANTIGEN, CONJUGATES AND USES THEREOF | Università Degli Studi Di Verona (IT) | 2011-02-16 | — | — | EP | disclosed |
| EP-1713514-A2 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | The Johns Hopkins University (US) | 2006-10-25 | — | — | EP | disclosed |
| WO-2005072710-A2 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | JOHNS HOPKINS UNIVERSITY (US) | 2005-08-11 | — | — | WO | disclosed |
| EP-1436429-A2 | TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO | THE GENERAL HOSPITAL CORPORATION (US) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003020949-A2 | TARGETED NUCLEIC ACID CONSTRUCTS AND USES RELATED THERETO | THE GENERAL HOSPITAL CORPORATION (US) | 2003-03-13 | — | — | WO | disclosed |
| EP-1135411-A1 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS INVOLVING EXCITOTOXICITY | BIOGEN, INC. (US) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000035948-A1 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS INVOLVING EXCITOTOXICITY | BIOGEN, INC. (US) | 2000-06-22 | — | — | WO | disclosed |